This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Auriga Laboratories, Inc.
Drug Names(s): dextroamphetamine sulfate generic
Liquadd is an oral solution of dextroamphetamine sulfate (5 mg/5 mL) designed for patients who have difficulty swallowing pills.
Liquadd is a generic of Dexedrine.
On December 3, 2007, Auriga announced its acquisition of an exclusive license from Outlook Pharmaceuticals, to make, distribute, commercialize, market and sell in the United States Liquadd.
Partners: Outlook Pharmaceuticals, Inc.
Additional information available to subscribers only: